Previous studies have demonstrated that IDH1/2 mutant cancer cells produce the tumor metabolite 2-hydroxyglutarate (2-HG) and that 2-HG-induced histone hypermethylation results in homology-directed repair defects. The gene discussed is IDH1; the disease is cancer.